The top 100 venture investors in biotech: Who’s in, what’s out

Endpoints News’ John Carroll and DealForma’s Chris Dokomajilar hosted a special webinar to discuss their latest ranking of the top 100 biotech VCs, examining the challenges and opportunities in a market facing an IPO drought and investor hesitancy. Listen to the webinar here.

All of this by stage, disease indication, modality, target…

+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures